跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-ACETAMINOPHEN 325MG - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-ACETAMINOPHEN 325MG
Authorized
STANDARD
M-ACETAMINOPHEN 325MG
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3f98068e91a715cb
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
3f98068e91a715cb
Drug Approval Canada Name
M-ACETAMINOPHEN 325MG
Product Name
M-ACETAMINOPHEN 325MG
Status
Cancelled Post Market
Status Date
2019-04-10
Original Market Date
2017-05-24
Din
02451018
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
OTC
Ahfs
28:08.92
Atc Original
N02BE01 ACETAMINOPHEN (PARACETAMOL)
Atc Name
n 02 be 01
Aig Number
0102009001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
ACETAMINOPHEN
325 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3f98068e91a715cb
Type
Standard
Back to Health Canada Approvals